Back to News
Market Impact: 0.12
EQT Foundation commits more than €1 million to help unlock new ways of delivering medicines to the brain
Source: PR Newswire
Healthcare & BiotechTechnology & Innovation
The EQT Foundation Science Grant is supporting 11 research projects aimed at improving delivery of therapeutics to the brain and central nervous system. Researchers are pursuing approaches to navigate the blood-brain barrier, including engineered biological carriers, which could advance treatment development for neurological conditions. The announcement is positive for early-stage biomedical innovation but is unlikely to have material near-term market impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
EQT0.15
More News
- ElevenLabs doubles its valuation to $22bn in a $300m share sale
- ElevenLabs’ valuation doubles to $22 billion on surging AI voice-agent demand
- Need Energy, Water Solutions With Data Centers: Jan Vesely
- Tencent leases 100,000 chips from Oracle for $7 bln- FT
- California Gov. Gavin Newsom bans AI 'robo bosses' in landmark state law, reversing his earlier veto
- Stocks Jump on inflation Surprise, Apple's Smart-Home Push